Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics, according to people familiar with the matter.

Challenging diplomatic talks are expected while tech titans fight for dominance in the fast-moving technology industry.

SpringWorks Therapeutics stock surged over Monday after a report from Reuters that German medical tech giant Merck KGaA could be close to acquiring the company.

Fresh off their Super Bowl halftime spectacle, Kendrick Lamar and SZA are expanding their upcoming tour to make stops in Europe.

By Shivansh Tiwary, Medha Singh and Chibuike Oguh NEW YORK (Reuters) -Shares of U.S. steel and aluminum producers rose on ...

Kellogg said he would unveil elements of the peace plan at the Munich Security Conference in Germany this weekend, according to the newspaper ...